Overview

Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury

Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate whether FX06 is capable of limiting infarct size following balloon catheterization for acute myocardial infarction.
Phase:
Phase 2
Details
Lead Sponsor:
Fibrex Medical Research & Development GmbH